Baxter International Inc (NYSE: BAX) |
|
BAX's Market share relative to its competitors, as of Q1 2025
As of Q1 2025 (Revenue in Millions of $)
Date modified: 2025-07-10T19:12:14+00:00
Select the Relationship:
|
|
Select the Category:
|
|
COMPANY NAME |
REVENUES 12 Months Ending Q1 2025 |
MARKET SHARE 12 Months Q1 2025 |
MARKET SHARE MRQ Q1 2025 |
MARKET SHARE A Quarter Before Q4 2024 |
Baxter International Inc |
9,669.00 |
1.63% |
1.81 % |
0.36 % |
Cardinal Health Inc |
222,127.00 |
37.51% |
37.80% |
37.17% |
Merck and Co Inc |
63,922.00 |
10.79% |
10.70% |
10.51% |
Pfizer Inc |
62,463.00 |
10.55% |
9.45% |
11.95% |
Abbott Laboratories |
42,344.00 |
7.15% |
7.14% |
7.38% |
Medtronic Plc |
33,199.00 |
5.61% |
5.71% |
5.65% |
3m Company |
24,513.00 |
4.14% |
4.10% |
4.04% |
Stryker Corp |
23,218.00 |
3.92% |
4.04% |
4.33% |
Fresenius Medical Care Ag |
21,788.05 |
3.68% |
3.68% |
0.00% |
Becton Dickinson And Company |
20,867.00 |
3.52% |
3.63% |
3.48% |
Boston Scientific Corporation |
17,553.00 |
2.96% |
3.21% |
3.07% |
Biogen Inc |
9,816.40 |
1.66% |
1.67% |
1.65% |
Edwards Lifesciences Corporation |
5,253.50 |
0.89% |
0.97% |
0.74% |
Resmed Inc |
4,895.80 |
0.83% |
0.88% |
0.82% |
Adapthealth Corp |
3,246.36 |
0.55% |
0.54% |
0.58% |
Teleflex Incorporated |
3,009.98 |
0.51% |
0.48% |
0.54% |
West Pharmaceutical Services Inc |
2,895.20 |
0.49% |
0.48% |
0.50% |
Icu Medical Inc |
2,419.91 |
0.41% |
0.42% |
0.42% |
Helen Of Troy Limited |
1,862.34 |
0.31% |
0.26% |
0.33% |
Integra Lifesciences Holdings Corp |
1,624.31 |
0.27% |
0.26% |
0.30% |
Merit Medical Systems Inc |
1,388.64 |
0.23% |
0.24% |
0.24% |
Haemonetics Corporation |
1,359.96 |
0.23% |
0.23% |
0.23% |
Livanova Plc |
1,275.26 |
0.22% |
0.22% |
0.22% |
Penumbra Inc |
1,240.10 |
0.21% |
0.22% |
0.21% |
Stevanato Group S p a |
1,215.60 |
0.21% |
0.21% |
0.00% |
Abiomed Inc |
1,074.10 |
0.18% |
0.18% |
0.19% |
Emergent Biosolutions Inc |
965.40 |
0.16% |
0.15% |
0.13% |
Inspire Medical Systems inc |
839.17 |
0.14% |
0.14% |
0.16% |
Shockwave Medical Inc |
787.37 |
0.13% |
0.15% |
0.14% |
Avanos Medical Inc |
649.00 |
0.11% |
0.11% |
0.00% |
Irhythm Technologies Inc |
618.23 |
0.10% |
0.11% |
0.11% |
Inari Medical Inc |
572.18 |
0.10% |
0.11% |
0.10% |
Transmedics Group Inc |
488.23 |
0.08% |
0.10% |
0.08% |
Atricure Inc |
478.88 |
0.08% |
0.08% |
0.08% |
Artivion Inc |
389.41 |
0.07% |
0.07% |
0.07% |
Angiodynamics Inc |
283.00 |
0.05% |
0.05% |
0.05% |
Cardiovascular Systems Inc |
239.84 |
0.04% |
0.04% |
0.04% |
Lemaitre Vascular Inc |
225.66 |
0.04% |
0.04% |
0.04% |
Axogen inc |
194.52 |
0.03% |
0.03% |
0.03% |
Atrion Corporation |
181.86 |
0.03% |
0.03% |
0.03% |
Surmodics Inc |
121.58 |
0.02% |
0.02% |
0.02% |
Outset Medical Inc |
115.42 |
0.02% |
0.02% |
0.02% |
Silk Road Medical Inc |
114.16 |
0.02% |
0.02% |
0.02% |
Piedmont Lithium Inc |
107.18 |
0.02% |
0.01% |
0.03% |
Rockwell Medical inc |
97.46 |
0.02% |
0.01% |
0.02% |
Meihua International Medical Technologies Co Ltd |
96.20 |
0.02% |
0.02% |
0.00% |
Avita Medical Inc |
71.66 |
0.01% |
0.01% |
0.01% |
Tela Bio Inc |
69.66 |
0.01% |
0.01% |
0.01% |
Cvrx inc |
53.12 |
0.01% |
0.01% |
0.01% |
Semler Scientific inc |
49.23 |
0.01% |
0.01% |
0.01% |
Utah Medical Products Inc |
36.94 |
0.01% |
0.01% |
0.00% |
Koru Medical Systems Inc |
35.08 |
0.01% |
0.01% |
0.01% |
Cytosorbents Corporation |
33.76 |
0.01% |
0.01% |
0.00% |
Jin Medical International Ltd |
19.82 |
0.00% |
0.00% |
0.00% |
Precision Optics Corporation Inc |
17.63 |
0.00% |
0.00% |
0.00% |
Inspiremd Inc |
6.51 |
0.00% |
0.00% |
0.00% |
Lucid Diagnostics Inc |
4.17 |
0.00% |
0.00% |
0.00% |
Orchestra Biomed Holdings Inc |
2.89 |
0.00% |
0.00% |
0.00% |
Catheter Precision Inc |
0.48 |
0.00% |
0.00% |
0.00% |
Yubo International Biotech Limited |
0.37 |
0.00% |
0.00% |
0.00% |
Nascent Biotech Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Non Invasive Monitoring Systems Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Ir med Inc |
0.00 |
0.00% |
0.00% |
0.00% |
Adagio Medical Holdings inc |
0.00 |
0.00% |
0.00% |
0.00% |
SUBTOTAL |
592,206.57 |
100% |
145,170.20 |
100% |
BAX's Market share relative to its competitors, as of Q1 2025 within the Medical Equipment & Supplies Industry
As of Q1 2025
BAX's Market share relative to its competitors, as of Q1 2025 within the Healthcare Sector
As of Q1 2025
Note: Market share is calculated based on total revenue. To get a more accurate picture of Baxter International Inc's market divisions, geographic dispersion, segments, products, and services, visit Baxter International Inc's Business Segment. The list includes publicly traded companies only. More information about the sources of this report can be found here.
|